1. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K: Mortality associated with influenza and respiratory syncytial virus in the United States. Jama-J Am Med Assoc. 2003, 289 (2): 179-186. 10.1001/jama.289.2.179.
2. Genzel Y, Reichl U: Continuous cell lines as a production system for influenza vaccines. Expert Rev Vaccines. 2009, 8 (12): 1681-1692. 10.1586/erv.09.128.
3. Nayak DP, Hui EKW, Barman S: Assembly and budding of influenza virus. Virus Res. 2004, 106 (2): 147-165. 10.1016/j.virusres.2004.08.012.
4. Cox NJ, Neumann G, Donis RO, Kawaoka Y: Orthomyxoviruses: Influenza. Topley & Wilson's Microbiology and Microbial Infections. Edited by: Mahy BWJ, ter Meulen V. 2010, John Wiley & Sons, Ltd, 3 and 4: 634-698. [
http://onlinelibrary.wiley.com/doi/10.1002/9780470688618.taw0238/abstract
]10
5. Ritter JB, Wahl AS, Freund S, Genzel Y, Reichl U: Metabolic effects of influenza virus infection in cultured animal cells: Intra- and extracellular metabolite profiling. Bmc Syst Biol. 2010, 4: